Editorial
 API MONITORING CELL   
 Tuesday, June 11, 2019 
 The twin issues of poor quality active pharmaceutical ingredients and its gyrating prices have been hitting the pharmaceutical industry in the country for quite some time. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Mereo BioPharma updates on its Etigilimab partnership
17:00  [IST]Tessa Therapeutics, CSGKC establish US$120 million JV in China to develop innovative cell therapies for cancer
16:00  [IST]111 enters partnership with Tong Ren Tang Technologies to advance "Internet + Healthcare"
15:00  [IST]Chi-Med's surufatinib phase III SANET-ep study meets primary endpoint at interim analysis in advanced non-pancreatic neuroendocrine tumors
14:00  [IST]Tecan launches optimized packaging for clear disposable tips
13:00  [IST]Univercells gets $14.3 mn grant from Bill & Melinda Gates Foundation to deliver affordable M&R vaccines using its NevoLine platform
more news >>
TOP NEWS
08:00  [IST]AIOCD opposes introduction of e-pharmacy for posing danger to patient safety
08:00  [IST]Separate regulatory conclave to be conducted as part of Pharmac South 2019 with participation from CDSCO
08:00  [IST]Centre approves draft Homoeopathy Central Council (Amendment) Bill, 2019
08:00  [IST]Saveetha Medical College & Hospital in Chennai to introduce Fellowship Programme in Medical Clowning
08:00  [IST]Union health minister appeals to gynaecologists & health activists for a ‘Jan Andolan’ for preventing maternal deaths
08:00  [IST]IDMA condemns USTR Report for making false allegation that 55% of global seizures of counterfeit drugs originated in India
more news >>
YESTERDAY'S NEWS
18:00  [IST]US FDA grants orphan drug status to Bolder BioTechnology's long-acting IL-11 analog, BBT-059 for acute radiation syndrome
17:00  [IST]BioInvent publishes first clinical data from BI-1206 phase l/lla trials
16:30  [IST]Pharmalytica 2019 in Mumbai witnesses participation from over 300 exhibitors
16:00  [IST]Crown Bioscience announces four new preclinical NASH models in development
15:45  [IST]Wockhardt scrip moves up on successful US FDA inspection
15:30  [IST]Biocon gets Certificate of GMP compliance from EMA for its biologics DP facility
more news >>
INTERVIEW  
Advanced flooring, integral part of pharma & healthcare infrastructure
Agradeep Mondal, Director Sales, Interface South Asia115398Agradeep
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the DoP's recent amendment to Para 32 of DPCO to provide 5-year price control exemption to patented innovative & rare diseases drugs a right move to increase accessibility ?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
Pharmatech-Expo-2019-Pharmabiz
CP: HI_Korea_2019_150x60
IPJ_2019_pharmabiz_150x60
Ipe_2019_150x 60
CPhI_Korea_2019_150x60
PharmaLytica150x60_2019
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |